Table 3.

Adverse events reported during the study

Adverse events	Avanafil (n = 111)	Sildenafil (n = 109)	P‐value
Headache	9 (8.1%)	10 (9.2%)	0.81
Flushing	0 (0.0%)	1 (0.9%)	0.50
Myalgia	0 (0.0%)	1 (0.9%)	0.50
Nasal congestion	0 (0.0%)	1 (0.9%)	0.50
Nausea	1 (0.9%)	0 (0.0%)	0.99
Fever	1 (0.9%)	0 (0.0%)	0.99
Back pain	2 (1.8%)	0 (0.0%)	0.50

Data presented as n (%). P‐value based on χ²‐test/Fisher’s exact test.